| Literature DB >> 17497267 |
Abstract
In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative.Entities:
Mesh:
Year: 2007 PMID: 17497267 PMCID: PMC3476138 DOI: 10.1007/s10194-007-0373-z
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277